Costco Wholesale closes on Hendersonville property
A store is already under construction on the 25-acre property, located off Vietnam Veterans Highway, and is expected to be open before the end of the year.
Nashville Business News – Local Nashville News | The Nashville Business Journal
Japan-based Kewpie Corp. closes on Clarksville property for $1.28M
The Japan-based company recently closed on the parcel that will host its 125,000 square foot production facility, which is currently under construction.
Nashville Business News – Local Nashville News | The Nashville Business Journal
Upperline Health closes $58.35 million round of funding
Founded in 2017 by former Aspire Health execs David Thorpe and Stephen Nash, Upperline Health is a network of physicians providing lower extremity (foot and ankle) care.
Nashville Business News – Local Nashville News | The Nashville Business Journal
Headquarters Beercade closes in downtown Nashville
Downtown Nashville’s Headquarters Beercade, by Chicago-based Machine Hospitality Group, closed its doors after opening in 2017.
Nashville Business News – Local Nashville News | The Nashville Business Journal
French markets skittish as far-right candidate Le Pen closes gap in election polls
French markets have been jolted as new polling shows far-right candidate Marine Le Pen closing the gap to incumbent President Emmanuel Macron.
International: Top News And Analysis
Lincoln Property Co. closes on SoBro land, bringing area holdings north of $86 million
This Dallas firm is buying big in SoBro. Its latest purchase was 2 acres near a fast-changing roundabout.
Bizjournals.com Nashville RSS Feed
Dow closes 500 points higher as major averages reclaim losses from earlier this week
U.S. stocks jumped Thursday as fears around a crisis in China’s property market eased and as the Fed kept current monetary stimulus in place for now.
International: Top News And Analysis
Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19
The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.
The ORCHID trial enrolled 479 adult patients hospitalized with COVID-19 in 11 weeks at 34 hospitals in the United States. It was a multicenter, blinded, placebo-controlled...